MASLD was rare (<10%) among patients with FCS caused by biallelic loss-of-function variants in LPL, APOC2, GPIHBP1, or LMF1, likely reflecting the absence of hepatic overproduction of triglyceride-rich lipoproteins in these monogenic forms. Here, APOC2 is linked to metabolic dysfunction-associated steatotic liver disease.